RhumbLine Advisers’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.4M Buy
643,856
+11,503
+2% +$272K 0.01% 922
2025
Q4
$20.5M Sell
632,353
-36,942
-6% -$1.58M 0.02% 701
2025
Q3
$38M Buy
669,295
+4,739
+0.7% +$243K 0.03% 468
2025
Q2
$33.1M Buy
664,556
+67,225
+11% +$3.04M 0.03% 502
2025
Q1
$17.7M Buy
597,331
+81,107
+16% +$3.01M 0.02% 749
2024
Q4
$12.5M Buy
516,224
+249,854
+94% +$6.19M 0.01% 954
2024
Q3
$4.91M Sell
266,370
-2,050
-0.8% -$36.7K ﹤0.01% 1438
2024
Q2
$5.42M Buy
268,420
+89,535
+50% +$1.49M 0.01% 1354
2024
Q1
$2.77M Buy
178,885
+1,896
+1% +$21.4K ﹤0.01% 1743
2023
Q4
$1.58M Sell
176,989
-7,865
-4% -$58.1K ﹤0.01% 2028
2023
Q3
$1.16M Sell
184,854
-30,641
-14% -$228K ﹤0.01% 2122
2023
Q2
$2.03M Buy
215,495
+36,064
+20% +$358K ﹤0.01% 1900
2023
Q1
$1.78M Buy
179,431
+3,214
+2% +$28.2K ﹤0.01% 1867
2022
Q4
$1.13M Buy
176,217
+2,855
+2% +$16.3K ﹤0.01% 2065
2022
Q3
$967K Buy
173,362
+20,161
+13% +$121K ﹤0.01% 2149
2022
Q2
$694K Buy
+153,201
New +$653K ﹤0.01% 2326

Other funds holding HIMS